---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-214711"
form_type: "8-K"
ticker: "PCVX"
cik: "0001649094"
company_name: "Vaxcyte, Inc."
filed_at: "2024-09-06T23:59:59+00:00"
generated_at: "2026-05-31T06:04:55.612096+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Vaxcyte raises $1.42B in underwritten public offering of common stock and pre-funded warrants

## Summary
- Sold 10,194,175 shares at $103.00/share and pre-funded warrants to purchase 2,427,184 shares at $102.999/warrant.
- Underwriters' 30-day option for additional 1,893,203 shares exercised in full.
- Net proceeds expected to be approximately $1.42 billion after discounts and expenses.
- Closing expected on or about September 6, 2024, subject to customary conditions.
- Offering made under effective shelf registration statement (Form S-3).

## SEC filing metadata
- accession: 0001193125-24-214711
- form_type: 8-K
- ticker: PCVX
- cik: 0001649094
- company_name: Vaxcyte, Inc.
- filed_at: 2024-09-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649094/000119312524214711/0001193125-24-214711-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649094/000119312524214711/d802914d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-214711
- JSON: https://secwatch.observer/filing/0001193125-24-214711.json
- Plain text: https://secwatch.observer/filing/0001193125-24-214711.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.